A formulation includes an active agent, a thickening/solidifying agent, and an antioxidant. The active agent is 9-cis-β-carotene (9CBC) or a derivative thereof of the following formula:

##STR00001##

where R.sub.2 is H or methyl; X is

##STR00002##

optionally substituted with one or more methyl groups; n is an integer of 0-16; and the asterisk represents the point of attachment to the cyclohexene ring.

The present invention relates to a method for total chemical synthesis of 9-cis-β-carotene (9CBC), and further provides stable formulations thereof.

The present invention relates to a method for total chemical synthesis of 9-cis-β-carotene (9CBC), and further provides stable formulations thereof.

The method begins with an oil which in one embodiment is cannabis crude oil derived from a cannabis plant. Oil is placed within a container having an open upper portion and with the oil preferably only filling up less than half of a volume of the container. The container and oil therein are placed within a vacuum oven where the oil is heated over time to a preselected temperature. A vacuum is then drawn on the oil while it is within the oven. Initial vacuum application is carefully applied to avoid the oil boiling over and out of the container. Vacuum residence time continues for a preselected duration, while gaseous terpenes are drawn from the oven toward the source of vacuum, such as a vacuum pump, by way of a cold trap/condenser. This cold trap is sufficiently cold that terpenes are condensed into a liquid form and collected therein.

The present invention relates to a method for total chemical synthesis of 9-cis--carotene (9CBC), and further provides stable formulations thereof.

The present invention provides methods and compositions for treating atopic dermatitis by cyclohexenone compounds.

The present invention provides beta-cryptoxanthin crystals from plant source and a process for its preparation. The present invention particularly relates to a process for the preparation of high purity beta-cryptoxanthin crystals comprising at least about 10% by weight total xanthophylls, of which at least about 75% by weight is trans-beta-cryptoxanthin and the remaining including beta-carotene, and trace amounts of trans-capsanthin and other carotenoids derived from the plant source, including capsicum fruits. The production of beta-cryptoxanthin crystals with high content of trans-beta-cryptoxanthin makes it ideal and suitable for use as a provitamin A source material and also has potential effects on improving bone health and inhibiting bone resorption.

The present invention provides beta-cryptoxanthin crystals from plant source and a process for its preparation. The present invention particularly relates to a process for the preparation of high purity beta-cryptoxanthin crystals comprising at least about 10% by weight total xanthophylls, of which at least about 75% by weight is trans-beta-cryptoxanthin and the remaining including beta-carotene, and trace amounts of trans-capsanthin and other carotenoids derived from the plant source, including capsicum fruits. The production of beta-cryptoxanthin crystals with high content of trans-beta-cryptoxanthin makes it ideal and suitable for use as a provitamin A source material and also has potential effects on improving bone health and inhibiting bone resorption.

The present application relates to processes for the preparation of polyhydroxylated cyclohexyl compounds of Formula I: ##STR00001##

The present invention provides beta-cryptoxanthin crystals from plant source and a process for its preparation. The present invention particularly relates to a process for the preparation of high purity beta-cryptoxanthin crystals comprising at least about 10% by weight total xanthophylls, of which at least about 75% by weight is trans-beta-cryptoxanthin and the remaining including beta-carotene, and trace amounts of trans-capsanthin and other carotenoids derived from the plant source, including capsicum fruits. The production of beta-cryptoxanthin crystals with high content of trans-beta-cryptoxanthin makes it ideal and suitable for use as a provitamin A source material and also has potential effects on improving bone health and inhibiting bone resorption.